{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:19:50Z","timestamp":1777180790034,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.cct.2014.06.014","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T02:37:35Z","timestamp":1404268655000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device\u00b1Metformin\u00b1weight loss in endometrial cancer (feMME) trial"],"prefix":"10.1016","volume":"39","clinical-trial-number":[{"clinical-trial-number":"nct00788671","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00909506","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01205672","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01302002","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01594879","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01686126","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01697566","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01943058","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02065687","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"A.L.","family":"Hawkes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Armes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Janda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2014.06.014_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cct.2014.06.014_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2009.03.039","article-title":"Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship","volume":"114","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0015","doi-asserted-by":"crossref","first-page":"349e1","DOI":"10.1016\/j.ajog.2010.05.004","article-title":"Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk","volume":"203","author":"Leitao","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2014.06.014_bb0020","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia","volume":"28","author":"Lacey","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jcp.24292","article-title":"Conservative treatment of early endometrial cancer","volume":"228","author":"Bovicelli","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cct.2014.06.014_bb0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0035","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cct.2014.06.014_bb0040","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/cncr.22351","article-title":"Treatment effects, toxicity, disease recurrence and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study","volume":"107","author":"von Gruenigen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0045","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2014.06.014_bb0050","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.cct.2014.06.014_bb0055","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1470-2045(09)70290-6","article-title":"Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Tangjitgamol","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0060","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ejca.2012.02.055","article-title":"Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: results from a randomised controlled trial","volume":"48","author":"Obermair","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0065","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.ejca.2012.03.013","article-title":"Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: results from a randomised controlled trial","volume":"48","author":"Kondalsamy-Chennakesavan","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajog.2012.01.010","article-title":"Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials","volume":"207","author":"Zullo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2014.06.014_bb0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/09513590902733733","article-title":"The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option","volume":"25","author":"Gadducci","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.cct.2014.06.014_bb0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0085","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/cncr.10435","article-title":"Fertility-preserving treatment in young patients with endometrial adenocarcinoma","volume":"94","author":"Wang","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0090","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/humrep\/del401","article-title":"Life 20years after unsuccessful infertility treatment","volume":"22","author":"Wirtberg","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cct.2014.06.014_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/CCO.0b013e32834d8155","article-title":"Metformin and cancer therapy","volume":"24","author":"Bost","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2011.06285.x","article-title":"Diabetes, cancer, and metformin: connections of metabolism and cell proliferation","volume":"1243","author":"Gallagher","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cct.2014.06.014_bb0105","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1940-6207.CAPR-10-0175","article-title":"Metformin and other biguanides in oncology: advancing the research agenda","volume":"3","author":"Pollak","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.cct.2014.06.014_bb0110","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.5519","article-title":"A preoperative window study of metformin for the treatment of endometrial cancer","volume":"31","author":"Schuler","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0115","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/jco.2014.32.15_suppl.5510","article-title":"Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study","volume":"32","author":"Soliman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2007.12.026","article-title":"Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial","volume":"109","author":"von Gruenigen","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2014.06.014_bb0130","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2014.06.014_bb0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ygyno.2012.03.042","article-title":"Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): a randomized controlled trial","volume":"125","author":"von Gruenigen","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.cct.2014.06.014_bb0140","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.26433","article-title":"The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer","volume":"131","author":"Nicklin","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0145","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.26433","article-title":"The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer","volume":"131","author":"Nicklin","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0150","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","article-title":"The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients","volume":"61","author":"Charlson","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cct.2014.06.014_bb0155","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"Bolen","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2014.06.014_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(11)61344-5","article-title":"Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial","volume":"378","author":"Jebb","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2014.06.014_bb0165","series-title":"Guideline for Good Clinical Practice","author":"ICH Expert Working Group","year":"1996"},{"key":"10.1016\/j.cct.2014.06.014_bb0170","series-title":"Common toxicity Criteria (CTC)","author":"EORTC","year":"2011"},{"key":"10.1016\/j.cct.2014.06.014_bb0175","series-title":"Manual of the functional assessment of chronic illness therapy (FACIT Scales) \u2013 Version 4","author":"Cella","year":"1997"},{"key":"10.1016\/j.cct.2014.06.014_bb0180","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.cct.2014.06.014_bb0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0895-4356(00)00261-4","article-title":"Self-reports of health care utilization compared to provider records","volume":"54","author":"Ritter","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cct.2014.06.014_bb0195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/nau.20934","article-title":"Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ)","volume":"30","author":"Barber","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.cct.2014.06.014_bb0200","series-title":"The Active Australia Survey: a Guide and Manual for Implementation, Analysis and Reporting","author":"AIHW","year":"2003"},{"key":"10.1016\/j.cct.2014.06.014_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7525-1-29","article-title":"The Hospital Anxiety And Depression Scale","volume":"1","author":"Snaith","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.cct.2014.06.014_bb0210","series-title":"Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System","article-title":"FACIT Manual","author":"Cella","year":"1997"},{"key":"10.1016\/j.cct.2014.06.014_bb0215","series-title":"Outcome Measures for Health Education and other Health Care Interventions","author":"Lorig","year":"1996"},{"key":"10.1016\/j.cct.2014.06.014_bb0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2014.06.014_bb0225","series-title":"Dietary Questionnaire for Epidemiologic Studies (Version 2)","author":"Giles","year":"1996"},{"key":"10.1016\/j.cct.2014.06.014_bb0230","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/02701367.1992.10607557","article-title":"Self-efficacy and the stages of exercise behavior change","volume":"63","author":"Marcus","year":"1992","journal-title":"Res Q Exerc Sport"},{"key":"10.1016\/j.cct.2014.06.014_bb0235","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0091-7435(87)90022-3","article-title":"The development of scales to measure social support for diet and exercise behaviors","volume":"16","author":"Sallis","year":"1987","journal-title":"Prev Med"},{"key":"10.1016\/j.cct.2014.06.014_bb0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","article-title":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature","volume":"125","author":"Baker","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0245","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jmig.2008.08.016","article-title":"Endometrioid adenocarcinoma after insertion of a levonorgestrel-releasing intrauterine system","volume":"15","author":"Flemming","year":"2008","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.cct.2014.06.014_bb0250","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2008.02.027","article-title":"Stage IV endometrial cancer after failed conservative management: a case report","volume":"111","author":"Kothari","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cct.2014.06.014_bb0255","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajog.2011.05.042","article-title":"Understanding obesity and endometrial cancer risk: opportunities for prevention","volume":"205","author":"Schmandt","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cct.2014.06.014_bb0260","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Dowling","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cct.2014.06.014_bb0265","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.cct.2014.06.014_bb0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cct.2014.06.014_bb0275","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0b013e3181719b92","article-title":"Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives","volume":"112","author":"Shen","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2014.06.014_bb0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/IGC.0b013e318207dac7","article-title":"Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression","volume":"21","author":"Zhang","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cct.2014.06.014_bb0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2010.12.006","article-title":"Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells","volume":"126","author":"Xie","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cct.2014.06.014_bb0290","series-title":"Social Foundations of thought and action: A social cognitive theory","author":"Bandura","year":"1986"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714414000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T21:29:29Z","timestamp":1598045369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714414000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1551714414000962"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2014.06.014","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device\u00b1Metformin\u00b1weight loss in endometrial cancer (feMME) trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2014.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}